You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses

Article metrics

Article menu

Download PDFPDF

Rheumatoid arthritis
Short report
Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses

 

Online download statistics by month:

Online download statistics by month: April 2022 to March 2024

AbstractFullPdf
Apr 2022732763273
May 202226126294
Jun 202212611731
Jul 2022746525
Aug 2022908737
Sep 202212612136
Oct 202215414442
Nov 202214314035
Dec 2022837635
Jan 2023867827
Feb 2023847630
Mar 2023867823
Apr 2023747018
May 2023444318
Jun 2023494715
Jul 2023373611
Aug 202331297
Sep 202326259
Oct 202331259
Nov 202350406
Dec 202321198
Jan 2024261914
Feb 2024454121
Mar 2024353449
Total25142435873